Follow Dr. Webster on Substack
Going forward, all my new articles will appear on Substack. This will give us a cleaner, more reliable way to stay connected with thoughtful, evidence-based commentary on pain, addiction, health policy, and the science that matters most to patients, and people interested in the health-related topics I write about.
Federally-Funded Research Might Someday Be Free A New Scientist article by Graham Lawton predicts that, by January 1, 2030, all biomedical research will be free to read. That might be an overly ambitious goal. It might not be a good idea, either. If research is federally funded, then perhaps — as Boingboing suggests — the…
Senator Ed Markey of MA Opposed DSUVIA According to a recent USA Today article, Senator Ed Markey of Massachusetts “urged the FDA not to approve Dsuvia last month, saying “an opioid that is a thousand times more powerful than morphine is a thousand times more likely to be abused, and a thousand times more likely to…
Medicare Rule Will Create New Challenges for Chronic Pain Patients Jacob Sullum recently wrote an article, “Medicare Rule Will Create New Challenges for Chronic Pain Patients,” for Practical Pain Management about the ways in which the pending Medicare changes will adversely affect chronic pain patients. As he explains, the new Medicare rule is intended to…
What’s Next? Midterms are behind us. You may be pleased or displeased with the results. Either way, the newly elected, and the reelected, senators and members of congress will now determine healthcare policy. They will take office in January. In the meantime, do your homework. When you’re worried that your doctor might be pressured to…
Vote to Change Healthcare Policies Mid-term elections are approaching. If you have the ability to vote, then this is a chance to help determine the direction of our healthcare policies. There are many issues important to each of us. To people who follow my blog, the most important healthcare issues have to do with how…
SUPPORT for Patients and Communities Act President Donald Trump signed the bi-partisan opioid legislation on October 24. According to Vox, the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act “is a big breakthrough that will boost access to addiction treatment and many other interventions to mitigate the…
Below is an edited excerpt from a chapter titled, Pharmacogenetics and Personalized Medicine in Pain Management, that Inna Belfer, MD PhD and I published in Clinics in Laboratory Medicine, Volume 36, Issue 3, September 2016. Personalized Pain Medicine Pharmacogenetic therapy in people with pain requires consideration of 2 different genetic substrates to determine the outcome…
On Friday, Oct. 12, 2018, AcelRex Pharmaceuticals, Inc. presented its case to the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (ADCOM) to discuss the approval of the new drug application (NDA) 209128 for DSUVIA™. DSUVIA is a small sufentanil pill deposited below the tongue with an applicator. It is…
Stefan G. Kertesz, MD Pens a Letter to the CDC Health Professionals Call on the CDC to Address Misapplication of Its Guideline on Opioids for Chronic Pain through Public Clarification and Impact Evaluation by Health Professionals for People in Pain is a letter that I recently had the privilege of signing. (Click here to see…
This is an article by Nancy Eugenie. I offer it with the author’s permission for informational purposes. The author and I have no financial involvement. THE VIEWS EXPRESSED BY THE AUTHOR ARE HER OWN AND DO NOT REPRESENT MY VIEW OR MEDICAL ADVICE. Coping With Pain One of the most difficult things about living with…
Recent Comments